CD19 and metastatic malignant neoplasm in the lymph nodes: In a study of B-cell subpopulations and various immunological deficits, Saudi and colleagues observed a substantial increase in CD19+ B cells in peripheral blood mononuclear cells of PCa patients with lymph node metastasis relative to those without lymph node metastasis.